Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

about

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease

P2860

Q55048859-7C783BF6-C3D7-4168-A5F6-67141CA8F6E5 Q55474333-449AB5B5-CA0E-4D89-9941-D7A6CFFFFBE8 Q58781782-348E190D-4125-4B6F-89FF-C18A44BBE00B

P2860

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

Item

http://www.wikidata.org/entity/Q47919912

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@en

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@nl

type

Item

label

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@en

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@nl

prefLabel

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@en

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@nl

P1476

Inactivation of glyceraldehyde ...... 4-dihydroxyphenylacetaldehyde.

@en

P2093

Arturo L Aguirre

http://www.w3.org/2001/XMLSchema#string

Brigitte C Vanle

http://www.w3.org/2001/XMLSchema#string

Daryl J Murry

http://www.w3.org/2001/XMLSchema#string

Jonathan A Doorn

http://www.w3.org/2001/XMLSchema#string

Virginia R Florang

http://www.w3.org/2001/XMLSchema#string

P2860

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

Alpha-synuclein in Lewy bodies

Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?

Protein aggregation and neurodegenerative disease

Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide

GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation

Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.

Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies.

Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

P304

275-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2017.08.067

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

492

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28830811

http://www.w3.org/2001/XMLSchema#string

P932

5746426

http://www.w3.org/2001/XMLSchema#string

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

about

P2860

P2860

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932